Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 33.16% is in line with its 5-year average of 34.33%, around the middle of its 5-year range (29.54%–37.77%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.19% above its 12-month average of 31.52%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 33.16%.
DEBT TO ASSETS RATIO
33.16%
DEBT TO ASSETS RATIO AVG TTM
31.52%
DEBT TO ASSETS RATIO AVG 3Y
34.75%
DEBT TO ASSETS RATIO AVG 5Y
34.33%
DEBT TO ASSETS RATIO AVG 10Y
30.19%
DEBT TO ASSETS RATIO AVG 15Y
29.45%
DEBT TO ASSETS RATIO AVG 20Y
29.91%
CURRENT VS TTM AVG
+5.19%
CURRENT VS 3Y AVG
-4.57%
CURRENT VS 5Y AVG
-3.42%
CURRENT VS 10Y AVG
+9.83%
CURRENT VS 15Y AVG
+12.57%
CURRENT VS 20Y AVG
+10.84%
SECTOR MEDIAN · HEALTHCARE
0.29%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
+11534.16%
vs the sector median at left
NeoGenomics, Inc.
Market Cap
$470.35M
Debt to Assets Ratio
33.16%
TTM Avg
31.52%
3Y Avg
34.75%
5Y Avg
34.33%
Market Cap
$389.98M
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$41.24M
Debt to Assets Ratio
0.50%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.71B
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.13B
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.49B
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeoGenomics, Inc. (NEO) | $470.35M | 33.16% | 31.52% | 34.75% | 34.33% |
| NRC Health (NRC)vs › | $459.30M | 0.66% | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $389.98M | 0.10% | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $41.24M | 0.50% | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.01B | 0.38% | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | 0.09% | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 0.44% | N/A | N/A | N/A |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.13B | 0.05% | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.49B | 0.18% | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | 0.59% | N/A | N/A | N/A |
Debt/Assets
33.2%
Debt/Equity
0.57
Current Ratio
3.60
Interest Coverage
-17.6x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 33.16% |
| 2026-03-31 | 30.34% |
| 2025-12-31 | 34.73% |
| 2025-09-30 | 29.85% |
| 2025-06-30 | 29.54% |
| 2025-03-31 | 37.77% |
| 2024-12-31 | 36.95% |
| 2024-09-30 | 36.94% |
| 2024-06-30 | 36.91% |
| 2024-03-31 | 37.08% |
| 2023-12-31 | 36.38% |
| 2023-09-30 | 36.09% |
| 2023-06-30 | 35.96% |
| 2023-03-31 | 35.71% |
| 2022-12-31 | 35.11% |
| 2022-09-30 | 34.84% |
| 2022-06-30 | 34.14% |
| 2022-03-31 | 33.52% |
| 2021-12-31 | 32.77% |
| 2021-09-30 | 32.15% |
| 2021-06-30 | 31.02% |
| 2021-03-31 | 39.13% |
| 2020-12-31 | 20.96% |
| 2020-09-30 | 22.86% |
| 2020-06-30 | 23.26% |
| 2020-03-31 | 20.95% |
| 2019-12-31 | 17.96% |
| 2019-09-30 | 19.18% |
| 2019-06-30 | 19.73% |
| 2019-03-31 | 24.54% |
| 2018-12-31 | 22.24% |
| 2018-09-30 | 24.24% |
| 2018-06-30 | 40.06% |
| 2018-03-31 | 28.93% |
| 2017-12-31 | 30.71% |
| 2017-09-30 | 30.55% |
| 2017-06-30 | 32.16% |
| 2017-03-31 | 32.30% |
| 2016-12-31 | 31.49% |
| 2016-09-30 | 17.82% |
| 2016-06-30 | 17.73% |
| 2016-03-31 | 17.67% |
| 2015-12-31 | 19.40% |
| 2015-09-30 | 11.88% |
| 2015-06-30 | 12.11% |
| 2015-03-31 | 12.43% |
| 2014-12-31 | 10.46% |
| 2014-09-30 | 10.62% |
| 2014-06-30 | 22.40% |
| 2014-03-31 | 28.03% |
| 2013-12-31 | 25.96% |
| 2013-09-30 | 22.69% |
| 2013-06-30 | 25.28% |
| 2013-03-31 | 27.70% |
| 2012-12-31 | 45.78% |
| 2012-09-30 | 47.63% |
| 2012-06-30 | 43.37% |
| 2012-03-31 | 45.46% |
| 2011-12-31 | 43.18% |
| 2011-09-30 | 45.32% |
| 2011-06-30 | 41.61% |
| 2011-03-31 | 45.19% |
| 2010-12-31 | 49.70% |
| 2010-09-30 | 51.34% |
| 2010-06-30 | 43.93% |
| 2010-03-31 | 41.55% |
| 2009-12-31 | 27.50% |
| 2009-09-30 | 19.84% |
| 2009-06-30 | 45.40% |
| 2009-03-31 | 39.70% |
| 2008-12-31 | 43.69% |
| 2008-09-30 | 33.39% |
| 2008-06-30 | 29.07% |
| 2008-05-13 | 18.95% |
| 2007-12-31 | 16.56% |
| 2007-09-30 | 14.20% |
| 2007-06-30 | 11.55% |
| 2007-05-11 | 17.61% |
| 2006-12-31 | 17.35% |
| 2006-09-30 | 67.86% |
| 2006-06-30 | 74.18% |
| 2006-03-31 | 76.50% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 126.51% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 96.26% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 134.68% |
| 2003-12-31 | 116.36% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 57.19% |
| 2002-12-31 | 3.02% |
| 2002-09-30 | 0.00% |
